home / stock / bfri / bfri news

BFRI News and Press, Biofrontera Inc. From 10/26/23

Stock Information
Company Name: Biofrontera Inc.
Stock Symbol: BFRI
Market: NASDAQ
Website: biofrontera-us.com
Menu
BFRI BFRI Quote BFRI Short BFRI News BFRI Articles BFRI Message Board
Get BFRI Alerts

News, Short Squeeze, Breakout and More Instantly...
BFRI - Align Technology, ImmunityBio

2023-10-26 09:56:33 ET More on Health Care Select Sector SPDR Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stocks to watch in the Health Care sector as earnings close in BofA reports 10th consecutive week of equity inflows For further detail...
BFRI - GRIN, BIOR and MTC among mid-day movers

2023-10-19 13:03:05 ET Gainers: WeBuy Global Ltd ( WBUY ) +138% . SeaStar Medical Holding Corp ( ICU ) +36% . Spectral AI MDAI +32% . Palatin Technologies PTN +29% . Mmtec ( MTC ) +29% . Maison Solutions ( MSS ) +26% . Bi...

BFRI - Lexicon Pharmaceuticals, Gritstone Bio among healthcare mover

2023-10-10 10:00:01 ET More on Health Care Select Sector SPDR Citi turns cautious on pharmaceuticals and biotech BofA Securities: Which small cap non-earner stocks to avoid Seeking Alpha’s Quant Rating on Health Care Select Sector SPDR For further deta...

BFRI - Biofrontera Inc. Receives FDA Approval for New Formulation of Ameluz(R)

Patent Application Filed with Potential to Extend Ameluz ® Protection to 2043 WOBURN, MA / ACCESSWIRE / October 10, 2023 / Biofrontera Inc. (NASDAQ:BFRI) ("Biofrontera" or the "Company") , a biopharmaceutical company specializing in the commercialization of dermatologic products, toda...
BFRI - Biofrontera files to sell shares, warrants

2023-10-05 12:45:42 ET More on Biofrontera Biofrontera Inc. (BFRI) Q2 2023 Earnings Call Transcript Biofrontera reports preliminary Q2 revenues $5.7M-$5.9M Seeking Alpha’s Quant Rating on Biofrontera Historical earnings data for Biofrontera Fin...

BFRI - Biofrontera Inc. to Participate in the Roth MKM 2023 Healthcare Opportunities Conference and the 43rd Annual Fall Clinical Dermatology Conference

WOBURN, MA / ACCESSWIRE / October 5, 2023 / Biofrontera Inc. (NASDAQ:BFRI) ("Biofrontera" or the "Company") , a biopharmaceutical company specializing in the commercialization of dermatologic products, today announced management will deliver a company presentation and hold investor meetings at th...

BFRI - Biofrontera sees Q3 revenue at $8.7M-$9M, backs FY23 revenue guidance

2023-10-05 06:10:24 ET More on Biofrontera Biofrontera Inc. (BFRI) Q2 2023 Earnings Call Transcript Biofrontera reports preliminary Q2 revenues $5.7M-$5.9M Seeking Alpha’s Quant Rating on Biofrontera Historical earnings data for Biofrontera Fin...
BFRI - Biofrontera Inc. Announces Preliminary Third Quarter Revenues

Revenues Increased 101% to 108% Over the Prior-Year Quarter Affirms Guidance for Full-Year Revenue Growth of at Least 25% over 2022 WOBURN, MA / ACCESSWIRE / October 4, 2023 / Biofrontera Inc. (NASDAQ:BFRI) ("Biofrontera" or the "Company") , a biopharmaceutical company specializing in th...

BFRI - Biofrontera Inc. Appoints Samantha Widdicombe to Support Commercial Relationships with Strategic Customer Accounts

WOBURN, MA / ACCESSWIRE / August 29, 2023 / Biofrontera Inc. (NASDAQ:BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic products, announced today the appointment of Samantha (Sam) Widdicombe to the newly created position of S...

BFRI - Biofrontera Inc. Announces Positive Results from Phase 1 Safety Study Evaluating Photodynamic Therapy with Three Tubes of Ameluz(R)

WOBURN, MA / ACCESSWIRE / August 28, 2023 / Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of dermatological products, announces positive topline results from its non-randomized, open-label, multicenter Phase 1 study evaluating t...
Previous 10 Next 10